90,000 Finns Use Semaglutide for Obesity, Kela Reimbursement Efforts Fail

Approximately 90,000 Finns used semaglutide for obesity last year, with Finns spending 66 million of their own money on obesity medications, while pharmaceutical companies' attempts to get obesity drugs covered by Kela reimbursements have been unsuccessful.